Literature DB >> 21307841

Mesenchymal stromal cells as treatment for chronic GVHD.

O Ringden, A Keating.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21307841     DOI： 10.1038/bmt.2010.275

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Oral mucosal progenitor cells are potently immunosuppressive in a dose-independent manner.

Authors:  Lindsay C Davies; Helena Lönnies; Matthew Locke; Berit Sundberg; Kerstin Rosendahl; Cecilia Götherström; Katarina Le Blanc; Phil Stephens
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

Review 2.  Stromal cells-are they really useful for GVHD?

Authors:  H Kaipe; T Erkers; B Sadeghi; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

3.  Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.

Authors:  Lieke C J van den Berk; Bas J H Jansen; Stuart Snowden; Kim G C Siebers-Vermeulen; Christian Gilissen; Gesine Kögler; Carl G Figdor; Craig E Wheelock; Ruurd Torensma
Journal:  Stem Cells Dev       Date:  2014-04-23       Impact factor: 3.272

4.  Early gestation chorionic villi-derived stromal cells for fetal tissue engineering.

Authors:  Lee Lankford; Taryn Selby; James Becker; Volodymyr Ryzhuk; Connor Long; Diana Farmer; Aijun Wang
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.

Authors:  Zyrafete Kuçi; Halvard Bönig; Hermann Kreyenberg; Milica Bunos; Anna Jauch; Johannes W G Janssen; Marijana Škifić; Kristina Michel; Ben Eising; Giovanna Lucchini; Shahrzad Bakhtiar; Johann Greil; Peter Lang; Oliver Basu; Irene von Luettichau; Ansgar Schulz; Karl-Walter Sykora; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Erhard Seifried; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

Review 6.  Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease.

Authors:  Sanaz Keshavarz Shahbaz; Amir Hossein Mansourabadi; Davood Jafari
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

7.  Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion.

Authors:  Pat P Y Chu; Sudipto Bari; Xiubo Fan; Florence P H Gay; Justina M L Ang; Gigi N C Chiu; Sai K Lim; William Y K Hwang
Journal:  Cytotherapy       Date:  2012-07-10       Impact factor: 5.414

8.  Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease.

Authors:  Sanaz Keshavarz Shahbaz; Amir Hossein Mansourabadi; Davood Jafari
Journal:  Clin Exp Immunol       Date:  2022-02-08       Impact factor: 5.732

Review 9.  Priming the Surface of Orthopedic Implants for Osteoblast Attachment in Bone Tissue Engineering.

Authors:  Kiat Hwa Chan; Shuangmu Zhuo; Ming Ni
Journal:  Int J Med Sci       Date:  2015-08-14       Impact factor: 3.738

Review 10.  Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?

Authors:  Gareth R Willis; Angeles Fernandez-Gonzalez; Monica Reis; S Alex Mitsialis; Stella Kourembanas
Journal:  Int J Mol Sci       Date:  2018-08-27       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.